AstraZeneca has temporarily put the brakes on its late-stage, global COVID-19 vaccine trial after a participant came down with what experts call an 'adverse event.' The promising vaccine candidate created by researchers at Oxford had been marching through rounds of clinical trials before word
AstraZeneca has temporarily put the brakes on its late-stage, global COVID-19 vaccine trial after a participant came down with what experts call an"adverse event."
"In pausing the trial, AstraZeneca is taking the time to thoroughly review the event and in doing so, ensuring the safety of the product is of highest priority," Durbin told ABC News. An AstraZeneca spokesperson said, in part,"There is no final diagnosis and there won’t be one until more test are carried out."
Story continuesThey may also review the frequency of similar adverse events in other trial participants, and look at any previous reports of transverse myelitis with other vaccines. "There's a lot more information that needs to be reviewed with this adverse event," Durbin said."You have to look at all the data in total and evaluate that against the risk of the disease you are trying to prevent."
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Why AstraZeneca pausing its COVID-19 vaccine trial may be good newsAstraZeneca has temporarily put the brakes on its late-stage, global COVID-19 vaccine trial after a participant came down with what experts call an 'adverse event.'
Read more »
AstraZeneca pauses Covid-19 vaccine trial – latest updatesA look at latest developments in global Covid-19 crisis👇: 💉 AstraZeneca suspends vaccine trial after one illness 🇬🇧 UK plans hiring spree to harness big data in virus recovery 🇧🇷 Brazil eyes vaccine rollout in January For more:
Read more »
AstraZeneca puts leading COVID-19 vaccine trial on hold over safety concernAstraZeneca Plc on Tuesday said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine because of an unexplained illness in a study participant.
Read more »
AstraZeneca Pauses COVID-19 Vaccine Trial Due To Volunteer's IllnessNPR's Noel King talks to Paul Offit of the Vaccine Education Center at Children's Hospital of Philadelphia, about the coronavirus vaccine trial developed by AstraZeneca and the University of Oxford.
Read more »
AstraZeneca Pauses Covid-19 Vaccine Trial After Illness in a U.K. SubjectAstraZeneca said it paused clinical trials of an experimental Covid-19 vaccine after a participant in a U.K. study had an unexplained illness.
Read more »
NIH director says it's 'reassuring' that AstraZeneca paused its COVID-19 vaccine trialsThe trials were halted after one study participant in the U.K. developed a neurological condition.
Read more »